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OBJECTIVES We studied left atrial volume (LAV) as an index of atrial size.
BACKGROUND Increased left atrial dimension (LAD) measured by M-mode echocardiography is a risk factor
for atrial fibrillation, stroke, and death.
METHODS A random sample of residents of Olmsted County, Minnesota, age 45 years (n  2,042)
underwent Doppler echocardiography with assessment of LAD and LAV. A subgroup of the
population (n  767) with no cardiovascular disease and normal systolic and diastolic
function was used to develop reference ranges for LAD and LAV. In the total population, the
prevalence of left atrial enlargement and the association between cardiovascular disease and
left atrial size as determined by both indexes were assessed.
RESULTS In the normal subgroup, both indexes were associated with gender and body size, thus models
controlling for body size were used to determine gender-specific reference ranges for LAD
and LAV. In the total population, left atrial enlargement was common, with a prevalence of
18% (men) and 12% (women) using LAD/body surface area (BSA) and of 16% (men and
women) using LAV/BSA. The agreement between the indexes was only fair (kappa  0.53).
Adjusting for age and gender, LAV/BSA was more strongly associated with the presence of
cardiovascular diseases than LAD/BSA.
CONCLUSIONS We described a simple technique of measuring LAV, examined methods for indexing LAV,
and described its normal range in a large, healthy reference cohort. Further, we find that in
the community, left atrial enlargement is common and reflects the burden of cardiovascular
disease. (J Am Coll Cardiol 2003;41:1036–43) © 2003 by the American College of
Cardiology Foundation
As measured by M-mode echocardiography, an increase in
left atrial dimension (LAD) is associated with cardiovascu-
lar disease and is a risk factor for atrial fibrillation, stroke,
and death (1,2). It has been suggested that left atrial volume
(LAV) may be a superior index of left atrial size (3).
Methods to calculate LAV (4,5) have been described, but no
standardized method has been widely adopted. Few studies
have compared LAD and LAV. Further, the distribution of
LAV in subjects without cardiovascular disease has not been
well described. Moreover, there is little agreement on how
to account for body size, age, or gender in setting the most
appropriate normal values for LAV. These factors have
hindered widespread reporting of LAV.
We used a simple and feasible method to assess LAV in
2,042 randomly selected residents of Olmsted County,
Minnesota, older than age 45 years. Our objectives were to
examine the influence of age, gender, and body size on LAD
and LAV in a reference subset of the population without
cardiovascular disease or cardiac dysfunction and to provide
adjusted reference ranges of LAD and LAV. Second, we
evaluated the strength of the association between LAD and
LAV and the presence of cardiovascular disease to deter-
mine if either index better reflected the effect of cardiovas-
cular disease on left atrial remodeling. Finally, we defined
the prevalence of left atrial enlargement in the population,
as assessed by each index, and examined the agreement
between LAV and LAD in defining left atrial enlargement.
METHODS
This study was approved by the Mayo Foundation Institu-
tional Review Board, and subjects gave written informed
consent.
Study setting. The characteristics of the Olmsted County,
Minnesota, population and its unique resources for
population-based epidemiologic research have been de-
scribed (6,7).
Population sampling, subject recruitment, and enroll-
ment. Randomly selected residents of Olmsted County age
45 years were invited to participate. A sampling fraction
of 7% was applied within each of the gender- and age- (five
years) specific strata. Subjects within each wave of invita-
tions were screened and recruited before initiating sub-
sequent waves in the three years ending in September 2000.
Of the 4,203 subjects invited, 2,042 (49%) participated.
Analysis of the medical records of the first 1,000 invited
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subjects revealed no clinically significant differences between
participants and nonparticipants.
Medical record review. Epidemiologic research in Olm-
sted County is feasible because all care providers have a
unified medical record indexed and maintained by the
Rochester Epidemiology Project. Each subject’s medical
record was reviewed by trained nurse abstractors using
established criteria for hypertension (8), myocardial infarc-
tion (9), and congestive heart failure (10). In addition,
clinical diagnoses of coronary artery disease and atrial
arrhythmias were recorded.
Doppler and two-dimensional (2D) echocardiography.
All echocardiograms were performed by one of three regis-
tered diagnostic cardiac sonographers with the same echo-
cardiographic instrument (HP-2500) according to a
standardized protocol and interpreted by one echocardiolo-
gist (M. M. R.). Two-dimensional and color Doppler
imaging were performed to screen for valvular stenosis or
regurgitation.
Assessment of cardiac structure. The LAD was measured
by 2D-guided M-mode echocardiography obtained in the
parasternal short-axis view at the base of the heart according
to American Society of Echocardiography recommenda-
tions (11). Three LADs were used to calculate LAV as an
ellipse using the formula: LAV  /6 (SA1  SA2  LA),
where SA1  the M-mode LAD and SA2 and LA are
measurements of short- and long-axis in the apical four-
chamber view (Fig. 1) (12) at ventricular end-systole. Body
size variables used for indexing included body surface area
(BSA) (m2), body mass index (BMI) (kg/m2), and height
(cm).
Assessment of ejection fraction (EF). In each subject,
measurement of EF by M-mode (modified Quinones for-
mula), quantitative 2D (biplane Simpson method of disks),
and semiquantitative 2D (visual estimate) methods was
performed as previously described (13,14).
Assessment of diastolic function. Pulsed-wave Doppler
examination of mitral (before and with Valsalva maneuver)
and pulmonary venous inflow and Doppler tissue imaging of
the mitral annulus were performed in each subject. Diastolic
function was categorized as: normal, impaired relaxation
(grade I), pseudonormalized filling (grade II), and restrictive
filling (grade III to IV), as previously described and vali-
dated (15,16).
Reference subgroup. Of the 2,042 participants, 1,020 had
no history of cardiovascular, renal, or pulmonary disease and
were taking no cardiovascular medications. Of these, 767
subjects had normal EF (50%), no wall motion abnormal-
ities, normal diastolic function, no valve disease, and normal
sinus rhythm. These 767 subjects form the normal sub-
group.
Statistical methods. Continuous variables are summarized
as the mean  1 SD, and comparisons between subjects
included or excluded from the reference group used the
Wilcoxon rank-sum test. Categorical variables are summa-
rized as a percentage of the group total, and the chi-squared
test was used for comparisons between subjects included in
the reference groups and those subjects who were excluded.
For the reference subgroup, the Spearman correlation coef-
ficient was used to assess the bivariate or pair-wise associ-
ation of left atrial size parameters with age and body size. In
addition, linear regression models were used to assess the
joint association of age, gender, and body size with left atrial
size. The prevalence of left atrial enlargement was estimated
in the total population by using the empirical 95th percen-
tile for LAD/BSA and LAV/BSA from the reference
subgroup, and the association of prevalent cardiovascular
abnormalities with prevalent left atrial enlargement was
summarized by using the odds ratio with corresponding
95% confidence intervals (CIs). To compare the strength of
association of LAD/BSA and LAV/BSA with cardiovascu-
lar abnormalities, the area under the receiver operating
characteristic curve for each index of left atrial size was
estimated and compared by the methods of DeLong et al.
(17). Comparisons between the area under the curve for
LAV/BSA and LAD/BSA were done unadjusted and
adjusted for age and gender.
Abbreviations and Acronyms
BMI  body mass index
BSA  body surface area
CI  confidence interval
EF  ejection fraction
LAD left atrial dimension
LAV  left atrial volume
2D  two-dimensional
Figure 1. (Left) Parasternal short-axis M-mode left atrial dimension.
(Right) Apical four-chamber view demonstrates short and long axes.
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RESULTS
Measurement of LAD was possible in 1,975 of the total
population-based cohort of 2,042 subjects (97%) and in 750
of the 767 subjects (98%) in the reference subgroup.
Measurement of LAV was possible in 1,888 of the 2,042
subjects (92%) and in 727 of the 767 subjects (95%) in the
reference subgroup. Data to calculate BSA were missing in
two of the subjects with LAV measurement.
LAD and LAV in normal subjects. Clinical characteristics
of subjects in the total population and stratified by inclusion
or exclusion from the reference subgroup are summarized in
Table 1. The reference subgroup contained 300 obese
participants (BMI 28 kg/m2). The LAV/BSA for obese
participants (mean SD, 22.85 5.40 ml/m2) was slightly
larger than for lean participants (BMI 28 kg/m2) who had
a mean LAV/BSA of 21.46  5.14 ml/m2.
Bivariable analysis showed that LAD and LAV were
larger in men and increased with body size or relative weight
(Table 2). There was a weak association of age with LAV.
Linear regression models incorporating gender, age, and
body size indexes (Table 3) accounted for 12% to 26% of the
variability in LAD in the reference subgroup, with higher
R2 values for models incorporating BSA and BMI than
those incorporating height. In particular, addition of BSA
to the model with age and gender increased the R2 from
12% to 23% and removed the effect of gender. When BMI
was added to age and gender, the R2 increased from 12% to
26%, without changing the association with gender. Height
had little additional impact on LAD, given age and gender,
with R2 remaining at 12%.
For LAV, models incorporating body size, age, and
gender accounted for 19% to 29% of the variability in LAV.
Similar to LAD, models using BSA and BMI had the
highest R2 values. Age was not associated with LAV, when
gender and body size measures were controlled. When
adjusting for body size using BMI or height, gender had a
highly significant association with LAV. This was not true,
however, when BSA was used to adjust for body size.
Both LAV and LAD were strongly associated with body
size. For those cardiac structural parameters associated with
body size, reference values are customarily reported cor-
rected for body size by means of indexation. By controlling
for body size with indexation to BSA, BMI, and height, the
association of LAD and LAV with age and gender was
investigated (Table 4). For LAD, age was associated with
LAD when indexed to BSA, BMI, or height, and gender
remained significant when LAD was indexed to BSA or
BMI. For LAV, no significant association with age was
present with indexation to BSA, BMI, or height. However,
males had significantly larger LAV in all three indexed
models.
Gender-specific reference ranges for left atrial dimension
and volume, with and without indexing, are provided in
Table 5.
Relationship between atrial size and cardiovascular dis-
ease in the entire cohort. The association between left
atrial size, as defined by quartiles of LAD/BSA or LAV/
BSA, and the presence of cardiovascular disease in the entire
cohort is shown in Table 6. Atrial size, by either parameter,
is significantly associated with the presence of cardiovascular
disease. Moreover, the unadjusted accuracy (area under the
receiver operating characteristic curve) was similar for each
atrial size parameter in relation to cardiovascular disease
except for congestive heart failure, where LAV/BSA had
significantly better accuracy than LAD/BSA (p  0.028).
However, when adjusting for age and gender, LAV/BSA
had better accuracy than LAD/BSA for hypertension (p 
0.0007), congestive heart failure (p  0.028), and atrial
fibrillation (p  0.0061).
Prevalence of left atrial enlargement in the population.
If left atrial enlargement is defined as LAV/BSA 95th
percentile in normal subjects, the prevalence of left atrial
Table 1. Characteristics of the Total Population, Reference Subgroup, and Abnormal Subgroup
Variables
Total Population
(n  2,041)
Reference Subgroup
(n  767)
Abnormal Subgroup*
(n  1,274)
p ValueMean SD Mean SD Mean SD
Women, % 51.84 NA 53.72 NA 50.71 NA 0.1876
Age, yrs 62.73 10.54 56.72 7.75 66.35 10.35  0.0001
BSA, m2 1.90 0.23 1.89 0.23 1.90 0.24 0.2974
BMI, kg/m2 28.44 5.31 27.62 4.73 28.94 5.57  0.0001
Height, cm 168.12 9.96 168.99 9.66 167.60 10.10 0.0021
LAD, cm 3.91 0.63 3.68 0.51 4.05 0.66  0.0001
LAV, ml 47.35 17.38 41.86 11.91 50.79 19.29  0.0001
*One subject was excluded as an outlier for LAV (500 ml).
BMI  body mass index; BSA  body surface area; LAD  left atrial dimension; LAV  left atrial volume; NA  not applicable.
Table 2. Association of LA Size With Age, Gender, and Body
Size by Bivariable Analysis in the Reference Subgroup
(n  767)
Variables
LA Dimension LA Volume
Spearman
(R2) p Value
Spearman
(R2) p Value
BSA 0.463  0.0001 0.542  0.0001
BMI 0.448  0.0001 0.411  0.0001
Height 0.299  0.0001 0.429  0.0001
Age 0.0003 0.9919 0.086 0.0208
Female gender 0.357  0.0001 0.408  0.0001
BMI  body mass index; BSA  body surface area; LA  left atrial.
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enlargement in the Olmsted County, Minnesota, popula-
tion was equal in men and women at 16% (CI, 14% to 19%
for both). The prevalence of left atrial enlargement by
LAD/BSA was 18% in men and 12% in women (CI, 15%
to 20% and 10% to 14%, respectively). The correspondence
between the two methods of defining left atrial enlargement
is shown in Table 7. Overall, there was 88% observed
concordance. However, this observed agreement was heavily
influenced by the large number of subjects without left atrial
enlargement. The Cohen kappa statistic was 0.54 (CI, 0.49
to 0.59), indicating only fair agreement. The Spearman
correlation between the two indexes was 0.65 (p  0.001).
When left atrial enlargement was defined by either index,
the odds ratio for the presence of cardiovascular disease with
left atrial enlargement was similar (Table 8).
DISCUSSION
A simple and feasible method to measure LAV was applied
in a cross-sectional sample of the population and compared
with the standard index of left atrial size, LAD. In a
subgroup of subjects without cardiovascular disease or car-
diac dysfunction (n  767), both indexes of left atrial size
increased with increasing body size and were larger in men.
The variability in body size, age, and gender explained up to
29% of the variability of left atrial size in the reference
subjects. When the association between left atrial size and
body size was controlled for by indexing to BSA, BMI, or
height, each indexed variable differed between men and
women, except LAD/height. In the reference subjects, there
was a positive association between indexed LAD and age,
although the magnitude of the change with age was not
clinically relevant. There was no association between age
and indexed or nonindexed LAV in the reference subjects.
In the entire population-based cohort, the prevalence of
cardiovascular disease increases with increasing LAD/BSA
and LAV/BSA. When adjusted for age and gender, LAV/
BSA exhibited a stronger association with cardiovascular
disease than LAD/BSA. Left atrial enlargement was com-
mon in the general population older than age 45 years, and
the prevalence of left atrial enlargement in the population
was somewhat higher when LAV/BSA was used to assess
left atrial size. The agreement between left atrial enlarge-
ment as defined by LAV/BSA and LAD/BSA was only fair.
However, left atrial enlargement as defined by either index
was associated with a similar prevalence of cardiovascular
disease.
LAV. Left atrial size, as measured by a single M-mode
dimension, is associated with the presence of cardiovascular
disease and is predictive of stroke, atrial fibrillation, and
death (1,2). It has been proposed that the left atrium
enlarges asymmetrically; hence, LAV, an index that encom-
passes multiplanar measurements, may be a more accurate
measure of atrial size. Although others have used the
four-chamber area-length and biplane Simpsons methods to
measure LAV (3,18,19), we used an elliptical model (12,20)
that incorporates two short-axis and one long-axis measure-
ment and does not require endocardial tracing or complex
calculations. Our median normal LAV/BSA values, 21
ml/m2 for women and 22 ml/m2 for men, are similar to the
mean values reported for both genders by using the biplane
Simpsons method (20  6 ml/m2) and the four-chamber
area-length method (21  7 ml/m2) in 48 normal volun-
teers by Wang et al. (18). The mean value reported by
Tsang et al. (21) using the biplane Simpsons method (22 
4 ml/m2) in 138 subjects with otherwise normal cardiac
structure and function is also similar to our data. We also
confirm that LAV/BSA, when adjusted for age and gender,
correlates better than LAD/BSA with the presence of
cardiovascular disease. These data suggest that this simple
method yields values that are similar to more complex
Table 3. Relationship Between Indexes of LA Size and Age, Gender, and Body Size by Multivariable Analysis in the Reference
Subgroup
Variables
LA Dimension LA Volume
Parameter
Estimate*
Confidence
Intervals p Value
Parameter
Estimate*
Confidence
Intervals p Value
Age 0.034 0.00, 0.07 0.0344 0.29 1.10, 0.52 0.4785
Female gender 0.35 0.42, 0.29  0.0001 9.58 11.19, 7.97  0.0001
Model summary R2  0.1193  0.0001 R2  0.1646  0.0001
Age 0.07 0.04, 0.10  0.0001 0.54 0.22, 1.30 0.1609
Female gender 0.05 0.14, 0.03 0.2289 1.77 3.77, 0.23 0.0827
BSA 0.22 0.18, 0.27  0.0001 5.82 4.82, 6.83  0.0001
Model summary R2  0.2256  0.0001 R2  0.2905  0.0001
Age 0.06 0.03, 0.09 0.0002 0.14 0.63, 0.91 0.7193
Female gender 0.28 0.34, 0.22  0.0001 8.07 9.61, 6.52  0.0001
BMI 0.20 0.17, 0.23  0.0001 4.01 3.20, 4.81  0.0001
Model summary R2  0.2647  0.0001 R2  0.2620  0.0001
Age 0.04 0.01, 0.08 0.0186 0.08 0.73, 0.88 0.8477
Female gender 0.29 0.40, 0.19  0.0001 4.70 7.07, 2.32 0.0001
Height 0.04 0.01, 0.10 0.1151 3.29 2.09, 4.49  0.0001
Model summary R2  0.1223  0.0001 R2  0.1968  0.0001
*Change in LA dimension or LA volume associated with a 1 SD increment in age or body size index within the reference subgroup.
BMI  body mass index; BSA  body surface area; LA  left atrial.
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methods of measuring LAV and reflects left atrial remod-
eling associated with cardiovascular disease. The large num-
ber of prospectively studied, rigorously selected reference
subjects and the population-based setting used in the
current study provide an appropriate venue for the definition
of “normal” reference values.
Although LAV is purported to be a superior method to
assess left atrial size, the optimal way to account for the
association between body size and LAV when reporting
LAV has not been established (22). Further, the need to
account for gender or age in the definition of upper normal
values is not clear from current literature. In the small
volunteer group in which normal values were previously
described for LAV, predominantly young subjects were
studied, and the number of subjects was insufficient to
determine if LAV varied with age, gender, or body size (18).
The Framingham study (23) indicated that LAD increased
with increasing body size and that BMI correlated with
LAD more strongly than weight or BSA. Yet, the data are
typically presented indexed to height, considered an intrin-
sic variable of body size that attempts to avoid problems
associated with overcorrection for the effect of obesity on
body size (24,25). In the current study, models incorporat-
ing BSA accounted for more of the variability in LAV in
normal subjects, suggesting that indexing to BSA is an
appropriate way to control for body size when reporting
LAV.
When considering the relationship between body size and
LAV in the reference cohort, we did not exclude subjects
who were obese if there was no known cardiovascular
disease or cardiac dysfunction. The relationship between
body size and LAV was stronger for body size indexes that
incorporate weight (BMI and BSA), as previously described
by Gottdiener et al. (26). Obese subjects free of cardiovas-
cular disease have larger (nonindexed) LAD (27), andTa
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Table 5. Reference Ranges for LAD and LAV From the
Reference Subgroup
Measurement Gender
Percentile
5% 50% 95%
LAD, cm Female 2.80 3.50 4.20
LAD, cm Male 3.00 3.90 4.60
LAD/BSA, cm/m2 Female 1.58 2.00 2.52
LAD/BSA, cm/m2 Male 1.49 1.88 2.30
LAD/BMI, cm/kg per m2 Female 0.100 0.131 0.176
LAD/BMI, cm/kg per m2 Male 0.101 0.137 0.172
LAD/height, cm/cm Female 0.017 0.022 0.026
LAD/height, cm/cm Male 0.017 0.022 0.027
LAV, ml Female 23 36 54
LAV, ml Male 29 45 69
LAV/BSA, ml/m2 Female 14 21 30
LAV/BSA, ml/m2 Male 14 22 33
LAV/BMI, ml/kg per m2 Female 0.94 1.37 2.07
LAV/BMI, ml/kg per m2 Male 1.02 1.61 2.47
LAV/height, ml/cm Female 0.144 0.226 0.333
LAV/height, ml/cm Male 0.164 0.257 0.390
BMI  body mass index; BSA  body surface area; LAD  left atrial dimension;
LAV  left atrial volume.
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weight loss is associated with a decrease in LAD (28).
Increases in stroke volume and cardiac output are needed to
meet the higher metabolic demands in obese subjects who
have larger blood volumes and left ventricular mass than
nonobese subjects (27). Indeed, nonobese athletes have
similar physiologic changes due to exercise and also have
larger atrial size (18,29). Although our reference values are
influenced by inclusion of overweight and obese individuals,
LAV/BSA was similar in lean (BMI 28 kg/m2) and
overweight or obese (BMI 28 kg/m2) normal subjects.
Prospective follow-up of this cohort may allow us to
determine whether the slightly larger LAV observed in an
obese individual reflects physiology or is an indicator of
covert cardiovascular disease. Indexing left atrial size vari-
ables to body size permits more uniform comparison
among subjects and may allow more accurate selection of
those with atrial enlargement related to cardiovascular
abnormalities.
Others (30 –32) have reported that LAD increases
slightly with age. In our study, age was significantly associ-
ated with LAD in the multivariate analysis. However, the
increment in LAD/BSA associated with an eight-year
increase in age was small (0.07 cm/m2) and is not likely to
be clinically relevant. In contrast, our data and that of others
suggest that increasing age is not associated with an increase
in LAV/BSA when excluding or controlling for the pres-
ence of cardiovascular disease (12,18).
In general, gender and body size are related. In the
multivariable analysis, the model combining age, gender,
and BSA suggested that gender was not independently
associated with LAV. However, when controlling for body
size by simply indexing LAV to BSA, we find a small but
significant difference between LAV/BSA in men and
women, suggesting the need for gender-specific reference
values for LAV/BSA.
Association of LAV and cardiovascular disease. The
traditional index of left atrial size, LAD, tends to be larger
in those individuals with cardiovascular disease (1,2). This
association likely reflects left atrial pressure and volume
Table 6. Association of Cardiovascular Disease and Indexes of Left Atrial Size in the
Population-Based Cohort*
Quartile
Unadjusted AUC
(95% CI)
Adjusted AUC†
(95% CI)1 2 3 4
LAD/BSA
Hypertension (%) 21.0 25.0 33.6 39.5 0.60 0.66†
(0.58, 0.63) (0.64, 0.69)
Coronary artery disease (%) 5.9 9.8 9.8 22.7 0.67 0.80
(0.63, 0.71) (0.77, 0.84)
Myocardial infarction (%) 2.6 3.9 3.5 9.3 0.65 0.80
(0.58, 0.71) (0.75, 0.84)
CHF (%) 0.4 1.2 0.4 6.5 0.83† 0.85†
(0.75, 0.91) (0.78, 0.92)
Valve disease (%) 0.8 1.6 2.9 11.1 0.80 0.84
(0.75, 0.86) (0.80, 0.89)
Atrial fib/flutter (%) 1.2 2.0 3.7 11.3 0.77 0.83†
(0.71, 0.82) (0.79, 0.88)
LAV/BSA
Hypertension (%) 20.4 24.6 28.0 43.2 0.62 0.68†
(0.59, 0.65) (0.65, 0.71)
Coronary artery disease (%) 5.3 8.3 8.7 24.8 0.70 0.81
(0.66, 0.74) (0.78, 0.84)
Myocardial infarction (%) 1.9 3.8 3.0 10.2 0.68 0.80
(0.62, 0.75) (0.76, 0.85)
CHF (%) 0 0.6 0.6 6.8 0.88† 0.89†
(0.83, 0.94) (0.84, 0.95)
Valve disease (%) 1.3 1.1 2.1 11.7 0.80 0.86
(0.75, 0.86) (0.82, 0.91)
Atrial fib/flutter (%) 1.1 1.7 2.3 13.6 0.80 0.86†
(0.75, 0.85) (0.82, 0.90)
The percentage of subjects with each cardiovascular condition within each quartile of left atrial size as defined by LAD/BSA and
LAV/BSA is shown. *For each cardiovascular disease, both unadjusted and adjusted LAV/BSA and LAD/BSA indexes had
significantly better than chance-predicted accuracy (p 0.0001); †p 0.05 for testing equality of AUC between LAV/BSA and
LAD/BSA.
AUC  area under curve; BSA  body surface area; CHF  congestive heart failure; fib  fibrillation; LAD  left atrial
dimension; LAV  left atrial volume.
Table 7. Agreement* Between Left Atrial Enlargement as Defined
by LAD/BSA or LAV/BSA in the Population-Based Cohort
Subjects, No. (n  1,886)
LAD/BSA Normal LAD/BSA Abnormal
LAV/BSA normal 1,474 104
LAV/BSA abnormal 127 181
*Observed agreement  88%; kappa  0.54 (0.49–0.59).
BSA body surface area; LAD left atrial dimension; LAV left atrial volume.
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overload in response to cardiac dysfunction associated with
cardiovascular diseases. The relationship between LAD and
the presence of atrial fibrillation is also well established (33).
As expected, in the current study, the prevalence of cardio-
vascular diseases increased with increasing LAV/BSA. The
association between cardiovascular disease and LAV/BSA
was stronger than that observed with LAD/BSA after
adjustment for age and gender.
Prevalence of left atrial enlargement in the population.
As defined by LAD or LAV, the prevalence of left atrial
enlargement in this middle-aged to elderly segment of the
population was significant: 16% in men and women by using
LAV/BSA and 18% (men) and 12% (women) by using
LAD/BSA. The high prevalence of left atrial enlargement
reflects the prevalence of cardiovascular disease in this
community-based population aged 45 years in which
29.5% had hypertension, 4.8% have had a myocardial
infarction, 2.2% had heart failure, 7.5% had diabetes, and
2.0% have had a stroke. These data are important because
the Framingham study has established that left atrial size
predicts development of atrial fibrillation, stroke, and death
in a community-based population. It remains unclear
whether subjects with left atrial enlargement should be
targeted for more aggressive intervention, as are patients
with hypertension or diabetes and target organ damage.
These cross-sectional data do not allow us to establish
that LAV is a better index of left atrial enlargement. Lester
et al. (3) suggested that the left atrium may become less
spherical as it enlarges and, thus, that LAV may be a more
sensitive index of left atrial enlargement. Indeed, Tsang et
al. (33) reported that LAV was more strongly associated
than LAD with the future development of atrial fibrillation
in a large clinical population. Although the prevalence of
cardiovascular disease was similar among those with left
atrial enlargement as defined by LAV and LAD, LAV
identified a slightly larger population with left atrial enlarge-
ment, and the agreement between the two indexes, as
defined by the kappa statistic, was only fair. These data
suggest that the two indexes identify somewhat different
segments of the population as abnormal. Thus, the potential
exists for LAV to be a more powerful predictor of future
cardiovascular events within the population, but it will
require large longitudinal studies in which standardized
increments in LAD and LAV are compared for their
predictive value.
In conclusion, our study describes a simple and highly
feasible method to quantify LAV, establishes the contribu-
tion of body size, gender, and age to LAV, provides normal
values for the index in a rigorously defined, population-
based reference population, and confirms the association of
LAV measured in this way with cardiovascular disease.
Although more time-consuming methodologies for measur-
ing LAV have been suggested, our data should enable
echocardiographic laboratories to incorporate this simple
and standardized measurement into their practice. We also
establish that left atrial enlargement is common in the
community and reflects the extent of cardiovascular disease
in those older than age 45 years.
Reprint requests and correspondence: Dr. Margaret M. Red-
field, Mayo Clinic, 200 First Street Southwest, Rochester, Min-
nesota 55905. E-mail: redfield.margaret@mayo.edu.
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